Latest stories on BRNS
Barinthus Biotherapeutics Completes Takeover and Delists ADSs
TipRanks50 · neutralgeneral
Barinthus Biotherapeutics plc. (BRNS) files 8-K
SEC 8-K50 · neutralgeneral
Barinthus Biotherapeutics advances court-approved merger, Nasdaq exit
TipRanks42 · neutralgeneral
Barinthus Biotherapeutics plc. (BRNS) files 8-K
SEC 8-K34 · bearishgeneral
Barinthus Biotherapeutics plc. (BRNS) files 8-K
SEC 8-K34 · bearishgeneral
Barinthus Bio Provides Update on Proposed Combination with Clywedog Therapeutics
GlobeNewswire56 · neutralm&a
Barinthus Biotherapeutics price target lowered to $6 from $7 at Alliance Global
The Fly38 · neutralanalyst
Barinthus Biotherapeutics plc. (BRNS) files 8-K
SEC 8-K50 · neutralgeneral
Barinthus Biotherapeutics Holds 2026 Annual General Meeting
TipRanks50 · neutralgeneral
Barinthus Biotherapeutics plc. (BRNS) files 8-K
SEC 8-K50 · neutralgeneral